文献速递免疫规划

白细胞介素38降低疫苗接种后的抗原提呈能力与抗体产生

Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination.
PubMed 文献 · Vaccine · 2024-09-30

研究探讨白细胞介素(IL)-38对固有免疫细胞抗原提呈能力及疫苗接种后抗体产生的影响。体外实验显示IL-38降低外周血单个核细胞HLA-DR、HLA-DM、CD83表达及髓系树突状细胞CD40、CD86表达,并损害单核细胞吞噬能力。在75名18-48岁接种BCG和Tdap-IPV的女性队列中,接种后至八个月针对白喉类毒素的抗体产生与血浆IL-38浓度呈负相关。

要点

  • IL-38降低外周血单个核细胞HLA-DR、HLA-DM和CD83表达,并降低髓系树突状细胞CD40和CD86表达。
  • IL-38损害单核细胞的吞噬能力。
  • 接种后至八个月针对白喉类毒素的抗体产生与血浆IL-38浓度呈负相关。

核心结论

  • IL-38可能削弱抗原提呈和吞噬作用,并可能因此调节某些疫苗类型的免疫原性。

研究设计与样本

  • 体外研究:重组人IL-38处理人外周血单个核细胞和髓系来源树突状细胞,检测细胞因子产生、吞噬作用及MHC II和共刺激蛋白表达。
  • 队列研究:75名18-48岁女性接种BCG和Tdap-IPV,分析血浆IL-38浓度与抗体应答的关系。

主要发现

  • IL-38降低外周血单个核细胞上HLA-DR、HLA-DM和CD83的表达。
  • IL-38降低髓系来源树突状细胞上CD40和CD86的表达。
  • IL-38损害单核细胞的吞噬能力。
  • 接种后至八个月针对白喉类毒素的抗体产生与血浆IL-38浓度呈负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The mechanisms that underpin low vaccine responses, which can lead to inadequate protection against infection, are still partially unclear. Interleukin (IL)-38 is a member of the IL-1 family, expressed by B cells among others, that regulates inflammatory responses. A recent study shows that IL-38 suppresses plasma cell generation and antibody production upon immune activation. We hypothesis that IL-38 affects antigen-presentation capacity of innate immune cells, effecting antibody production. Here, we investigated the effect of recombinant human IL-38 on human peripheral blood mononuclear cells and myeloid-derived DCs regarding cytokine production, phagocytosis, and expression of MCH II and co-stimulatory proteins in vitro, and further relate circulating plasma IL-38 concentrations to antibody responses in a cohort of 75 females aged 18-48 vaccinated with BCG and Tdap-IPV. To this end, we found that IL-38 decreased the expression of HLA-DR, HLA-DM, and CD83 on PBMCs, and CD40 and CD86 on MDDCs. IL-38 further impaired phagocytosis capacity of monocytes. Lastly, antibody production against diphtheria toxoids up to eight months post-vaccination was negatively associated with IL-38 plasma concentrations. These data suggest that IL-38 could dampen the effectiveness of antigen-presentation and phagocytosis, and could therefore modulate the immunogenicity of some vaccine types.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Teufel LU, Taks EJM, van Gemert J, et al. Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination. Vaccine. 2024. PMID: 39353267. doi:10.1016/j.vaccine.2024.126396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。